Related Experiment Video

Updated: Aug 19, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

[Peculiarities of nervous system lesions in patients with multiple myeloma]

V N Ardashev, A P Seriakov, E V Kostenko

    Voenno-Meditsinskii Zhurnal
    |January 29, 2005
    PubMed

    Insights

    Multiple myeloma (MM) patients frequently experience polyneuropathy (41.4%) and spinal cord involvement (13.8%). Spinal cord issues significantly increase mortality risk, unlike peripheral polyneuropathy alone.

    Area of Science:

    • Hematology
    • Neurology
    • Oncology

    Context:

    • Multiple myeloma (MM) is a B-cell lymphoproliferative disorder.
    • Neurological complications, including polyneuropathy and spinal cord involvement, can affect MM patients.
    • Understanding the prevalence and impact of these complications is crucial for patient management.

    Purpose:

    • To investigate the prevalence of polyneuropathy and spinal cord involvement in patients with multiple myeloma.
    • To analyze the relationship between neurological involvement and disease severity or prognosis in MM.
    • To determine the specific types and outcomes associated with neurological complications in MM.

    Summary:

    • This study analyzed 174 multiple myeloma patients, finding polyneuropathy in 41.4% and spinal cord involvement in 13.8%.
    • Sensorimotor polyneuropathy was the most common type (76.4%).
    • While peripheral polyneuropathy showed no significant prognostic link, spinal cord involvement was associated with a substantially higher short-term mortality risk (0.26 probability within 1 month).

    Impact:

    • Highlights the significant prevalence of neurological complications in multiple myeloma.
    • Emphasizes the critical prognostic importance of spinal cord involvement in MM patients.
    • Suggests a distinct interrelation between nervous system involvement and disease severity, impacting patient outcomes.

    More Related Videos

    Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice05:32

    Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

    Published on: January 7, 2019

    Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models08:57

    Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

    Published on: May 17, 2024

    Related Concept Videos

    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
    Neural Regulation01:37

    Neural Regulation

    Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
    Myasthenia Gravis ll: Pathophysiology01:22

    Myasthenia Gravis ll: Pathophysiology

    The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
    Alterations in Muscle Tone lll01:11

    Alterations in Muscle Tone lll

    Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
    Disorders of the Skeletal Muscle01:28

    Disorders of the Skeletal Muscle

    The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
    Musculoskeletal disorders
    Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...